Curcumin may impair iron status when fed to mice for six months

Redox Biology

Volumn 2, Issue 1, 2014, Pages 563-569

  Chin, Dawn ^a   Huebbe, Patricia ^a   Frank, Jan ^b   Rimbach, Gerald ^a   Pallauf, Kathrin ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Curcumin; Enlarged spleen; Iron store; Liver minerals; Safety; Toxicity

Indexed keywords

CD71 ANTIGEN; COPPER; CURCUMIN; FERRITIN; HEME OXYGENASE 1; HEPCIDIN; IRON; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NUCLEAR FACTOR; ZINC; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE EXACERBATION; FEMALE; GENE EXPRESSION; GENE TARGETING; HEPATITIS; HOMEOSTASIS; IRON BALANCE; IRON DEFICIENCY; IRON STORAGE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN DISEASE; ADVERSE EFFECTS; ANIMAL; BODY WEIGHT; C57BL MOUSE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIVER; METABOLISM; SPLEEN; SPLENOMEGALY; ADULT; BIOSAFETY; GENE SEQUENCE; LIVER PARENCHYMA; STORAGE DISEASE;

ANIMALS; BODY WEIGHT; COPPER; CURCUMIN; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERRITINS; GENE EXPRESSION REGULATION; HEPCIDINS; IRON; LIVER; MICE; MICE, INBRED C57BL; SPLEEN; SPLENOMEGALY; ZINC;

MUS;

EID: 84896032976     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.01.018     Document Type: Article

References (51)

1. Esatbeyoglu T., Huebbe P., Ernst I.M., Chin D., Wagner A.E., Rimbach G. Curcumin-from molecule to biological function. Angew. Chem. Int. Ed. Engl. 2012, 51:5308-5332.
2. Eigner D., Scholz D. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J. Ethnopharmacol. 1999, 67:1-6.
3. Chin D., Huebbe P., Pallauf K., Rimbach G. Neuroprotective properties of curcumin in Alzheimer's disease-merits and limitations. Curr. Med. Chem. 2013, 20:3955-3985.
4. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21:2895-2900.
5. Jackson S.J., Murphy L.L., Venema R.C., Singletary K.W., Young A.J. Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation. Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2013, 60C:431-438.
6. Borsari M., Ferrari E., Grandi R., Saladini M. Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability. Inorg. Chim. Acta 2002, 328:61-68.
7. Bernabe-Pineda M., Ramirez-Silva M.T., Romero-Romo M.A., Gonzalez-Vergara E., Rojas-Hernandez A. Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin-Fe(III)-water and Curcumin-Fe(II)-water. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2004, 60:1105-1113.
8. Dairam A., Fogel R., Daya S., Limson J.L. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J. Agric. Food Chem. 2008, 56:3350-3356.
9. Tuntipopipat S., Judprasong K., Zeder C., Wasantwisut E., Winichagoon P., Charoenkiatkul S., et al. Chili, but not turmeric, inhibits iron absorption in young women from an iron-fortified composite meal. J. Nutr. 2006, 136:2970-2974.
10. Jiao Y., Wilkinson J.T., Di X., Wang W., Hatcher H., Kock N.D., et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 2009, 113:462-469.
11. Srivastava K.C., Bordia A., Verma S.K. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot. Essent. Fatty Acids 1995, 52:223-227.
12. Shah B.H., Nawaz Z., Pertani S.A., Roomi A., Mahmood H., Saeed S.A., et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem. Pharmacol. 1999, 58:1167-1172.
13. Prakash P., Misra A., Surin W.R., Jain M., Bhatta R.S., Pal R., et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb. Res. 2011, 127:111-118.
14. Kim D.C., Ku S.K., Bae J.S. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012, 45:221-226.
15. Schiborr C., Eckert G.P., Rimbach G., Frank J. A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal. Bioanal. Chem. 2010, 397:1917-1925.
16. Ringman J.M., Frautschy S.A., Teng E., Begum A.N., Bardens J., Beigi M., et al. Oral curcumin for Alzheimer[U+05F3]s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther. 2012, 4:43.
17. Gupta S.C., Kismali G., Aggarwal B.B. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 2013, 39:2-13.
18. Siebert F., Luhken G., Pallauf J., Erhardt G. Mutation in porcine Zip4-like zinc transporter is associated with pancreatic zinc concentration and apparent zinc absorption. Br. J. Nutr. 2013, 109:969-976.
19. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., et al. Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 2004, 79:502-509.
20. Lonnerdal B. Dietary factors influencing zinc absorption. J. Nutr. 2000, 130:1378S-1383SS.
21. Matak P., Zumerle S., Mastrogiannaki M., El Balkhi S., Delga S., Mathieu J.R., et al. Copper deficiency leads to anemia, duodenal hypoxia, upregulation of HIF-2alpha and altered expression of iron absorption genes in mice. PLoS One 2013, 8:e59538.
22. Baum L., Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer[U+05F3]s disease animal models. J. Alzheimers Dis. 2004, 6:367-377. (discussion 443-9).
23. Zhang Y., Golub L.M., Johnson F., Wishnia A. pKa zinc- and serum albumin-binding of curcumin and two novel biologically-active chemically-modified curcumins. Curr. Med. Chem. 2012, 19:4367-4375.
24. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
25. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
26. Begum A.N., Jones M.R., Lim G.P., Morihara T., Kim P., Heath D.D., et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer[U+05F3]s disease. J. Pharmacol. Exp. Ther. 2008, 326:196-208.
27. B.B. Aggarwal, S.C.Gupta, B.Sung, Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers, Br. J. Pharmacol. 169 (2013) 1672-1692
28. Motterlini R., Foresti R., Bassi R., Green C.J. Curcumin an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 2000, 28:1303-1312.
29. Scapagnini G., Colombrita C., Amadio M., D'Agata V., Arcelli E., Sapienza M., et al. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox Signal. 2006, 8:395-403.
30. McNally S.J., Harrison E.M., Ross J.A., Garden O.J., Wigmore S.J. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int. J. Mol. Med. 2007, 19:165-172.
31. Jiao Y., Wilkinson J.T., Christine Pietsch E., Buss J.L., Wang W., Planalp R., et al. Iron chelation in the biological activity of curcumin. Free Radic. Biol. Med. 2006, 40:1152-1160.
32. Chung J., Kim M.S., Han S.N. Diet-induced obesity leads to decreased hepatic iron storage in mice. Nutr. Res. 2011, 31:915-921.
33. Sonnweber T., Ress C., Nairz M., Theurl I., Schroll A., Murphy A.T., et al. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J. Nutr. Biochem. 2012, 23:1600-1608.
34. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 2001, 276:7811-7819.
35. Nemeth E. Iron regulation and erythropoiesis. Curr. Opin. Hematol. 2008, 15:169-175.
36. Ward D.M., Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochim. Biophys. Acta 2012, 1823:1426-1433.
37. Ramey G., Deschemin J.C., Durel B., Canonne-Hergaux F., Nicolas G., Vaulont S. Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica 2010, 95:501-504.
38. Schiborr C., Eckert G.P., Weissenberger J., Muller W.E., Schwamm D., Grune T., et al. Cardiac oxidative stress and inflammation are similar in SAMP8 and SAMR1 mice and unaltered by curcumin and Ginkgo biloba extract intake. Curr. Pharm. Biotechnol. 2010, 11:861-867.
39. Schiborr C., Schwamm D., Kocher A., Rimbach G., Eckert G.P., Frank J. The senescence-accelerated mouse-prone 8 is not a suitable model for the investigation of cardiac inflammation and oxidative stress and their modulation by dietary phytochemicals. Pharmacol. Res.: Off. J. Ital. Pharmacol. Soc. 2013, 74:113-120.
40. Nishinaka T., Ichijo Y., Ito M., Kimura M., Katsuyama M., Iwata K., et al. Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element. Toxicol. Lett. 2007, 170:238-247.
41. Garg R., Gupta S., Maru G.B. Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 2008, 29:1022-1032.
42. Gibson J.N., Jellen L.C., Unger E.L., Morahan G., Mehta M., Earley C.J., et al. Genetic analysis of iron-deficiency effects on the mouse spleen. Mamm. Genome 2011, 22:556-562.
43. Helyar L., Sherman A.R. Moderate and severe iron-deficiency lowers numbers of spleen lymphocyte-T and lymphocyte-B subsets in the C57/B16 mouse. Nutr. Res. 1992, 12:1113-1122.
44. Kuvibidila S.R., Velez M., Gardner R., Penugonda K., Chandra L.C., Yu L. Iron deficiency reduces serum and in vitro secretion of interleukin-4 in mice independent of altered spleen cell proliferation. Nutr. Res. 2012, 32:107-115.
45. Gardenghi S., Grady R.W., Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia. Hematol. Oncol. Clin. North Am. 2010, 24:1089-1107.
46. Eckert G.P., Schiborr C., Hagl S., Abdel-Kader R., Muller W.E., Rimbach G., et al. Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8. Neurochem. Int. 2013, 62:595-602.
47. Kamal-Eldin A., Frank J., Razdan A., Tengblad S., Basu S., Vessby B. Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 2000, 35:427-435.
48. Vathsala P.G., Dende C., Nagaraj V.A., Bhattacharya D., Das G., Rangarajan P.N., et al. Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation. PLoS One 2012, 7:e29442.
49. Kakkar V., Singh S., Singla D., Sahwney S., Chauhan A.S., Singh G., et al. Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2010, 878:3427-3431.
50. Dadhaniya P., Patel C., Muchhara J., Bhadja N., Mathuria N., Vachhani K., et al. Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies. Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2011, 49:1834-1842.
51. Schiborr C., Kocher A., Behnam D., Jandasek J., Toelstede S., Frank J. The oral bioavailability of curcumin from micronized poweder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res. 2014, 58:516-527.